EMA Guidance on Trial Mgmt during COVID-19

Health Care, Pharma Industry, Strategic Planning

The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.

Read the Guidance now

 

Related Education Resources.

All Resources

Countdown to Brexit: Can your clinical supply chain pass the Brexit pressure test

Topics: Pharma Industry, Politics

White Paper

Members

Envisioning the Future of Clinical Supply Chains in the Next 10 Years

Topic: Supply Chain

Executive Summary

Members

Challenges of the Cell, Gene, CAR-T and Personalized Medicine Supply Chains

Topics: Cold Chain, Conference, Supply Chain

Video

Members

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.

Join Renew